RHBC
R.H. Bluestein & Co’s CRISPR Therapeutics CRSP Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $372K | Sell |
5,700
-150
| -3% | -$9.79K | 0.02% | 191 |
|
|
2022
Q2 | $356K | Sell |
5,850
-10
| -0.2% | -$609 | 0.02% | 209 |
|
|
2022
Q1 | $368K | Sell |
5,860
-415
| -7% | -$26.1K | 0.02% | 252 |
|
|
2021
Q4 | $476K | Sell |
6,275
-1,000
| -14% | -$75.9K | 0.02% | 221 |
|
|
2021
Q3 | $814K | Sell |
7,275
-4,750
| -40% | -$531K | 0.03% | 140 |
|
|
2021
Q2 | $1.95M | Buy |
12,025
+4,575
| +61% | +$741K | 0.08% | 72 |
|
|
2021
Q1 | $908K | Buy |
7,450
+900
| +14% | +$110K | 0.04% | 112 |
|
|
2020
Q4 | $1M | Buy |
6,550
+850
| +15% | +$130K | 0.04% | 101 |
|
|
2020
Q3 | $477K | Sell |
5,700
-300
| -5% | -$25.1K | 0.02% | 166 |
|
|
2020
Q2 | $441K | Sell |
6,000
-75,642
| -93% | -$5.56M | 0.02% | 165 |
|
|
2020
Q1 | $3.46M | Buy |
81,642
+71,142
| +678% | +$3.02M | 0.29% | 50 |
|
|
2019
Q4 | $640K | Buy |
10,500
+3,400
| +48% | +$207K | 0.03% | 129 |
|
|
2019
Q3 | $291K | Sell |
7,100
-400
| -5% | -$16.4K | 0.02% | 255 |
|
|
2019
Q2 | $353K | Buy |
+7,500
| New | +$353K | 0.02% | 197 |
|